Atossa Therapeutics: Betting Big On Transforming Old Breast Cancer Care (NASDAQ:ATOS)

Unrecognizable female gynocologist looking at a mammogram at the hospital


Topline Summary

Atossa Therapeutics (NASDAQ:ATOS) in a biotech company focused on the development of a novel hormone therapy for women with the most common subgroup of breast cancer: hormone receptor-positive disease. Although they have funds to continue for a few more

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *